Cannabis Rescheduling

Are The Illicit Market, Curaleaf And Trulieve The 3 Biggest Winners From Rescheduling Cannabis?
EXCLUSIVE: We Analyzed 4,000+ DEA Marijuana Rescheduling Comments; Here's What Americans Really Think
Ted Cruz Blasts Biden's Cannabis Rescheduling Plan, Says 'Drugged Driving' Will Lead To Car Accidents, Deaths
EXCLUSIVE: We Analyzed 4,000+ DEA Marijuana Rescheduling Comments; Here's What Americans Really Think
Ted Cruz Blasts Biden's Cannabis Rescheduling Plan, Says 'Drugged Driving' Will Lead To Car Accidents, Deaths
How Will Cannabis Rescheduling Impact Commercial Real Estate
Rescheduling Marijuana Is 'Unjustifiable Abdication Of Responsibility' Says Black Cannabis Lawyers Assn. Urges Full Decriminalization

Cannabis Rescheduling Recent News

[Infographic] DEA's Proposed Rules For Marijuana: What You Need To Know
The Dept. of Justice (DOJ) proposes rescheduling marijuana to Schedule III under the Controlled Substances Act.
Cannabis Rescheduling: When Will It Happen? Expert Lays Out Timeline, Risks And Wild Cards
The Department of Justice (DOJ) confirmed that it has started the formal rulemaking process to reclassify cannabis to Schedule III. This significant step reinforces the positive outlook for cannabis stocks.
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Curaleaf's Boris Jordan Says Rescheduling Cannabis Will Save His Company $200M In Revenue, Bring Illicit Market In From The Cold (CORRECTED)
Attorney General Merrick Garland Initiates Process To Reschedule Cannabis With DOJ Legal Review, Where's The DEA?
AG Merrick Garland formally initiated the rescheduling process that includes a 60-day public comment period.
Finally, Tax Refunds! These Cannabis Companies Will Get The Most Money Back If Rescheduling Happens
Significant tax benefits are anticipated for the cannabis industry, following President Joe Biden's confirmation of the administration's intent to reschedule cannabis from Schedule I to Schedule III.
Biden's Greenlight: What To Know About Fed-Regulated Marijuana, Markets, Legal Circuits And Compliance
In an exclusive interview with Benzinga Cannabis, Aaron Bloom, an attorney and CEO of DocMJ, a multistate cannabis clinic, delved into the legal steps for rescheduling cannabis to Schedule III in the
Weed Industry Celebrates Biden's Rescheduling Move: 'Most Monumental Cannabis Reform In Half A Century'
Cannabis companies and advocates applaud President Biden's announcement to reschedule and legalize cannabis, calling it a major leap forward and opportunity to correct long-standing wrongs and improve the industry's cashflow.
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.
Congressman Blumenauer Calls Marijuana Schedule III Status 'A Revolutionary Step' But 'Not Quite What We Wanted,' Here's Why
Prompted by Attorney General Merrick Garland's proposal to reclassify marijuana from Schedule I to Schedule III, Congressman Earl Blumenauer, founder and co-chair of the Congressional Cannabis Caucus, continues to push President Joe Biden's administration to put an end to the failed federal prohibition of cannabis. In an updated cannabis policy memorandum issued on Tuesday, the Congress' top cannabis advocate signaled optimism.  
DEA And Cannabis Rescheduling: A Rollercoaster Ride You Don't Want To Miss, But Keep Your Seatbelts On
DEA's decision not to sign the rescheduling order caused a roller coaster ride for the cannabis industry, with more confusion ahead.
GOP Senator Bashes Dems' Push For Marijuana Legalization As Pro-Criminal & Anti-American: 'It's Obscene'
GOP Senator Bill Hagerty accused the Democrats of pursuing policies that are pro-criminal and anti-American.
Former FDA Agent Says Big Pharma Not Likely To Get Involved In Cannabis Industry After Rescheduling
Canadian Giant SNDL Speeds Up Acquisition Of Majority Positions In Two US Cannabis Companies As Marijuana Rescheduling Looms
SNDL Inc. through its joint venture with SunStream Bancorp Inc., announced on Thursday that SunStream USA group of companies will proceed with the process of acquisition of equity positions in U.S. cannabis assets, following the completion of a review by SNDL's listing authority, NASDAQ. SunStream USA I, LLC and SunStream USA II, LLC are among the entities that comprise the SunStream USA Group, with each entity including one or more third-party investors, all independently managed and governed.The Calgary, Alberta-based company said on Thursday that SNDL's affiliate, SunStream Opportunities II LP, is anticipated to own non-voting and non-participating exchangeable securities in the SunStream USA entities.  
Is Cannabis Rescheduling Imminent?
Rumors of an imminent drug policy announcement swept through the industry Tuesday morning after the Associated Press reported the Drug Enforcement Administration (DEA) plans to reschedule cannabis.
Trump Vs. Biden: The President Plays The Marijuana Rescheduling Card, Voters Like The Thought Of It
"By the end of the poll, impressions of Biden improve by a net double-digits — an 11-point swing overall," survey shows.
Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly traded market for cannabis companies.
Lawmakers Warren, Schumer, Fetterman, Lankford And Others On DEA's 'Common Sense' Or 'Irresponsible' Cannabis Rescheduling
Rep Blumenauer On Marijuana Reclassification: 'Legalization Is Inevitable, Biden-Harris Admin Is Listening' To The People
In a landmark decision that could reshape the landscape of American drug policy, the U.S.
DEA's Move To Reclassify Cannabis Seen As 'Significant,' But Fails To Resolve State-Federal Conflict
DEA calls for reclassification of botanical cannabis from Schedule I to III under federal law. NORML praises decision but cautions on state/federal divide.
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decision to align its stance with a recommendation from the Department of Health and Human Services and move
The Medical Cannabis Explosion Just Got Real
The global cannabis trifecta has hit! The United States has finally rescheduled cannabis, moving it to Schedule III; the Department of Health and Human Services (HHS) and Food and Drug Administration (FDA) have released a report deeming cannabis a safe medicine; and Germany has removed the narcotics derivation from cannabis, making it easy to prescribe. 
DEA Public Comment Period And A Cannabis-Related Crypto Bill? You Heard It First At Benzinga Conference
In Beacon Securities's latest report issued after the Benzinga Cannabis Capital Conference in Florida, analysts delved into significant developments and key conversations that are shaping the future of the cannabis industry.